Radionuclide method for evaluating the performance of hemodialysis in vivo  by Bihl, Geoffrey R. et al.
Kidney International, Vol. 67 (2005), pp. 721–731
Radionuclide method for evaluating the performance
of hemodialysis in vivo
GEOFFREY R. BIHL,1 NICHOLAS J. BIRD, CHRISTINA PETERS, JOHN R. BRADLEY,
and A. MICHAEL PETERS2
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Radionuclide method for evaluating the performance of
hemodialysis in vivo.
Background. Specifications of dialyzer performance are gen-
erally based on in vitro measurements. There is, however, a
shortage of data on dialyzer performance in vivo. The aim of this
study was to use continuous measurement of technetium-99m-
diethyltriaminepentaacetic acid (Tc-99m-DTPA) blood con-
centration as a means of continuously monitoring dialyzer func-
tion in vivo in patients undergoing routine hemodialysis.
Methods. The study population comprised 15 patients (45 to
80 years old; 13 males). Tc-99m-DTPA was administered in-
travenously 90 minutes before obtaining a blood sample and
starting dialysis. Blood Tc-99m-DTPA activity was continuously
monitored by passing the line carrying blood from the patient to
the dialyzer close to a scintillation probe mounted in a shielded
housing. At the end of hemodialysis, lasting 180 to 300 minutes,
chromium-51-ethylenediaminetetraacetic acid (Cr-51-EDTA)
was given intravenously and a blood sample taken 90 minutes
later. Baseline dialyzer blood flow (Qb) and dialysate flow (Qd)
were 250 to 350 mL/min and 500 mL/min, respectively. The rate
constant, a, of the decrease in blood Tc-99m-DTPA activity was
used as the measure of moment-to-moment dialyzer function.
Pre- and postdialysis extracellular fluid volumes were calculated
from the blood Tc-99m-DTPA and Cr-51-EDTA concentrations
(VDTPA and VEDTA) before and after dialysis. Tc-99m-DTPA
clearance was measured as the product of a and VDTPA. Dia-
lyzer urea clearance was calculated from pre- and postdialysis
urea nitrogen concentrations and the time of dialysis. The ef-
fects of brief changes in Qb and Qd on dialyzer function were
assessed from the associated changes in a.
Results. The Tc-99m-DTPA clearance profile was biexponen-
tial, becoming monoexponential about 1 hour after starting
hemodialysis, with a remaining constant for as long as dialy-
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sis continued in five patients in whom Qb and Qd were left
unaltered. Mean (SEM) plasma Tc-99m-DTPA clearance av-
eraged over the entire period of dialysis in all 15 patients was
110 (3.1) mL/min. It correlated with urea clearance (r = 0.71)
(P < 0.01) which was 225 (9.5) mL/min based on a total body
water of 2.5 that of VDTPA and 212 (13) mL/min scaled to 40
L/1.73 m2. Extracellular fluid volume decreased by 1.73 (0.74)
l over dialysis, which was comparable to the change in weight
[1.48 (0.57) kg]. The extraction fraction of Tc-99m-DTPA across
the artificial kidney, directly measured from afferent and effer-
ent blood samples under baseline Qb and Qd, was 0.5 (0.013).
Average extraction fraction indirectly estimated from Tc-99m-
DTPA blood clearance and Qb was 0.54 (0.019). These two
measurements of extraction fraction correlated with each other
under conditions of varying Qb and Qd (r = 0.74) (N = 27)
(P < 0.001). Changes in a resulting from changes in Qb and Qd
were similar to changes predicted from computerized model-
ing. The ratio of mass transfer coefficients of urea and Tc-99m-
DTPA with respect to the dialyzer, calculated as if they were
permeability-surface area products, was 3.3, similar to the ratio,
obtained from the literature, in continuous capillary endothe-
lium.
Conclusion. Tc-99m-DTPA is a useful agent for continuously
monitoring dialyzer function in vivo and provides a platform for
the use of other radio-pharmaceuticals of different molecular
sizes that could be used in an analogous fashion.
The conventional benchmark by which to assess the
effectiveness of a single session of haemodialysis is urea
removal [1], which is conventionally expressed as the quo-
tient, Kt/V, where K is blood urea clearance, t is time of
dialysis, and V is urea distribution volume. A major per-
formance specification of a dialyzer is the mass trans-
fer area coefficient of urea which is the urea flux per
unit concentration gradient. Mass transfer area coeffi-
cient is analogous to permeability surface area (PS) prod-
uct which is similarly defined as the solute flux (mg.min−1)
per unit concentration gradient (mg.mL−1) across capil-
lary endothelium in vivo in a specific capillary vascular
bed and which has units of mL.min−1. Dialysis removes
many other soluble substances with a range of molecular
sizes, and therefore a range of permeability coefficients,
toward the top end of which is urea. Insofar as urea is a
relatively small and relatively highly diffusible molecule,
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Table 1. Clinical details
Weight kgAge Height
Patient Gender years Hematocrit cm Pre- Post- ln Rurea ln RDTPA Kt/V eKt/V
1 M 52 0.37 175 70.4 68.5 1.30 1.59 1.47 1.32
2 M 58 0.40 178 72.3 69.9 1.27 1.54 1.44 1.30
3 F 70 0.32 157 61.5 59.3 N/A N/A N/A N/A
4 M 80 0.29 168 84.3 83.8 0.96 1.24 1.05 0.95
5 M 66 0.26 168 63.3 63.5 0.84 1.17 0.90 0.78
6 M 64 0.26 180 97.6 94.0 1.05 1.50 1.23 1.14
7 M 70 0.33 175 68.7 68.0 1.00 1.23 1.09 0.94
8 M 72 0.36 180 80.2 78.3 1.22 1.37 1.38 1.24
9 M 64 0.29 168 61.0 59.4 1.14 1.46 1.29 1.16
10 M 55 0.31 170 113.7 113.5 0.77 0.99 0.83 0.72
11 F 68 0.31 165 61.2 59.3 1.02 1.09 1.14 0.98
12 M 66 0.39 168 81.6 80.5 1.03 1.20 1.12 0.97
13 M 64 0.28 168 59.5 57.5 1.16 1.55 1.30 1.12
14 M 62 0.21 173 70.8 67.6 0.70 0.87 0.80 0.70
15 M 48 0.37 175 94.2 92.0 N/A 0.84 N/A N/A
R is the ratio of concentrations of respective indicator in the blood samples taken before dialysis started and immediately before its termination. Kt/V for urea is
a conventional measure of delivered dialysis calculated using the formula of Daugirdas [10]: Kt/V = ln[(Rurea – 0.008 ∗ T)] + [(4 – 3.5 ∗ R) ∗ UF/W], where t is time
of dialysis in minutes and T in hours, and UF/W is weight difference/predialysis weight. “Equilibrated” Kt/V (eKt/V) has been corrected for rebound using a further
formula [10]: eKt/V = Kt/V – (0.46 ∗ [Kt/V]/T) + 0.02. Urea rebound is the% difference between Kt/V and eKt/V.
its transport in a dialyzer is blood flow-dependent at
standard levels of dialyzer blood flow (Qb). It provides,
therefore, an overrepresentation of dialyzer function, in
that clearance of larger molecules would be expected
to be less blood flow-dependent at the levels of flow
used.
Measurement of dialyzer permeability coefficients in
vivo have been difficult because of uncertainties about
constancy of dialyzer function over time especially in re-
lation to membrane fouling by plasma proteins which
may alter transport properties [2, 3]. Technetium-99m-
diethylenetriaminepentaacetic acid (Tc-99m-DTPA) is
an inert diffusible hydrophilic solute of molecular
weight 492 D. It has been used widely over many
years for gamma camera renography [4] and, as it
shares essentially the same properties as chromium-51-
ethylenediaminetetraacetic acid (Cr-51-EDTA) (360 D),
is also a useful radiotracer for measuring glomerular fil-
tration rate (GFR) [5, 6]. Because Tc-99m-DTPA is an
excellent gamma emitter, we decided to explore the value
of Tc-99m-DTPA for “real-time” monitoring of dialysis
performance in a manner analogous to the way it has pre-
viously been used for “real-time” monitoring of GFR,
including immediate responses of GFR to interventions
such as adenosine infusion [7] and administration of po-
tentially nephrotoxic agents like radiologic contrast me-
dia [8]. Exploitation of it in this way relies on the fact
that the rate constant (a) of disappearance from its dis-
tribution volume (VDTPA) is very close to the ratio of its
clearance (almost identical to that of inulin) and distribu-
tion volume. Any change in clearance without a change in
distribution volume is reflected in a change in a. The effi-
ciency with which the signal emitted by Tc-99m-DTPA is
detected following intravenous injection can be improved
in the dialysis setting by placing the detector in close prox-
imity to one of the vascular lines exchanging blood be-
tween the patient and the dialyzer. Using multichannel
detectors it would be possible moreover to monitor more
than one gamma-emitting radiotracer continuously but
in this preliminary study we have focused exclusively on
Tc-99m-DTPA.
The aims of the study, therefore, were first to determine
if dialyzer performance displayed any evidence of deteri-
oration toward the end of a dialysis session, which would
be indicated by a steady decrease in a; second, to compare
Tc-99m-DTPA clearance kinetics with those of urea; and
third, to see if we could detect and quantify changes in
Tc-99m-DTPA clearance in response to changes in ma-
chine paremeters, namely Qb, and dialysate flow rate
(Qd). Because Tc-99m-DTPA is an efficient gamma emit-
ter, it is also feasible to make parallel physiologic mea-
surements of dialyzer performance by obtaining simulta-
neous blood samples from either side of the dialyzer and
measuring extraction fraction (E). By comparing clear-
ance measured as the product of E and Qb with clearance
measured as the product of VDTPA and a, we were able
to assess the robustness of Tc-99m-DTPA for continuous
real-time measurement of dialyzer function.
METHODS
Patients
Fifteen patients on long-term hemodialysis were re-
cruited (Table 1). Thirteen were males and the age range
was 48 to 80 years (median 66 years). They were all es-
sentially anephric with GFRs less than 5 mL/min/1.73 m2.
The study was approved by the Local Research Ethics
Committee and the Administration of Radioactive Sub-
stances Advisory Committee of the United Kingdom.
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Radiopharmaceuticals
Tc-99m-DTPA and Cr-51-EDTA were obtained from
Amersham Healthcare (Bucks, UK) and dispensed ac-
cording to the manufacturer’s instructions.
Procedures
Prior to dialysis, patients were injected intravenously
with 150 to 200 mBq of Tc-99m-DTPA. After 90 min-
utes, a venous blood sample was taken to estimate the
distribution volume (VDTPA) of this radiotracer. Dialysis
was then started and continued for 3 to 5 hours. Another
blood sample was taken from the line carrying blood from
the patient to dialyzer immediately before the termina-
tion of dialysis and between 15 seconds and 2 minutes
after slowing dialyzer blood flow down to 50 mL/min
(in two patients, this blood sample was omitted). In six
patients, Cr-51-EDTA (2 mBq) was also given immedi-
ately after the termination of dialysis, and, after a fur-
ther period of 90 minutes, a final blood sample was taken
to estimate the postdialysis distribution volume (VEDTA)
of this radiotracer. Tc-99m-DTPA and Cr-51-EDTA, be-
ing crystalloids of similar molecular size (492 and 360 D,
respectively), have essentially identical distribution vol-
umes (∼15 L in normal subjects) [5, 6]. Additional blood
samples were obtained during dialysis to estimate the
dialyzer Tc-99m-DTPA extraction fraction (see below).
Patients were weighed immediately before and after
dialysis.
A shielded housing was built through which the plastic
line taking blood from the patient to the dialyzer was fed
and in which a 5 cm sodium iodide scintillation detector
was placed. The housing was designed so that the line
passed across the face of the detector, which was con-
nected to a PC-based Multi-Channel Analyzer (MCA)
system (Ortec Maestro, Oak Ridge, TN, USA) set to dy-
namically acquire counts in 1-minute bins, thereby en-
abling the blood concentration of Tc-99m-DTPA to be
plotted continuously as a function of time throughout
dialysis.
Plasma from the blood samples was counted for Cr-
51-EDTA and Tc-99m-DTPA in an automatic gamma
counter (Wallac-Wizard, Turku, Finland). Where both
radionuclides were present in the sample, correction
was made for the cross-talk between the Cr-51-EDTA
and Tc-99m-DTPA windows. The dialysis machine was
a Fresenius 4008 and two different types of dialyzer
were used (Althin A-18 in seven patients and Fresenius
F-8 in eight patients) (Fresenius, Bad Homburg, Ger-
many). The initial blood flow rate dialed into the dia-
lyzer machine was usually 300 mL/min (12/15 patients),
although it ranged from 250 to 350 mL/min. The initial
dialysate flow rate was 500 mL/min in all patients. In
five patients, these baseline flow rates were left unaltered
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Fig. 1. Plasma technetium-99m-diethyltriaminepentaacetic acid (Tc-
99m-DTPA) concentration recorded continuously for 4 hours after the
onset of dialysis in two patients. One (VDTPA = 15.7) was dialyzed with
A-18 (upper profile, t1/2 113 minutes from 60 minutes) and the other
(VDTPA = 18.8) with F-8 (lower profile, t1/2 130 minutes from 60 min-
utes). In both patients, the radiotracer was administered intravenously
90 minutes before onset of dialysis and in both, the clearance profile
approached a single exponential over the first 60 minutes after which it
clearly remained monoexponential until the termination of dialysis.
throughout dialysis while in ten patients Qb and Qd were
changed in isolation for periods of 20 minutes starting
1 hour after the onset of dialysis. The flow rates were
returned to their respective baseline values for at least
15 minutes before making another change. The changes
comprised a 33% reduction in Qb, a 60% increase in
Qd (to 800 mL/min) and a 40% decrease in Qd (to
300 mL/min).
Data analysis
Volumes of distribution. The volumes of distribution
of Tc-99m-DTPA (VDTPA) and Cr-51-EDTA (VEDTA)
were, respectively, calculated from the blood samples
taken just before the start of dialysis and, in six patients,
90 minutes after the termination of dialysis by simple di-
lution analysis. These volumes are close to extracellular
fluid volume. In order to calculate the Tc-99m-DTPA “re-
bound,” the Tc-99m-DTPA concentration in the sample
taken 90 minutes after the finish of dialysis was compared
with that in the sample taken just before the termination
of dialysis from which postdialysis urea concentration was
measured.
Tc-99m-DTPA clearance. Ignoring the first 60 min-
utes after the start of dialysis, during which reequilibra-
tion of Tc-99m-DTPA takes place (see Fig. 1 and Ap-
pendix 1), a least squares exponential fit was applied to
the entire disappearance curve (or segments of it in the
patients in whom flow rates were altered; see below) to
give the rate constant, a. This rate constant is close to the
ratio of plasma Tc-99m-DTPA clearance (plasmaKDTPA)
and VDTPA. In fact, a is slightly less than this ratio by
an amount that is dependent on a [9]. It was therefore
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subjected to a correction, to give a corr using a previ-
ously published formula that is itself a function of the
recorded value of a [9]. plasmaKDTPA was therefore calcu-
lated as the product of a corr and VDTPA. Although VDTPA
changed slightly over the course of dialysis, the predial-
ysis value, determined with Tc-99m-DTPA, was used to
calculate plasmaKDTPA. Urea distributes between plasma
and red cells so blood clearance is the appropriate ex-
pression for urea clearance but Tc-99m-DTPA does not
enter red cells so plasma clearance is usually used. Nev-
ertheless plasmaKDTPA was converted to blood clearance
(bloodKDTPA) by dividing it by (1 – hematocrit).
bloodKDTPA averaged out for the whole period of dial-
ysis (except the first 60 minutes) was based on the value
of a corr that was obtained by performing a least squares
fit to the time-dependent blood Tc-99m-DTPA concen-
tration from 60 minutes after the start of dialysis to the
termination of it (ignoring the brief periods during which
changes in Qb and Qd were made). The average extrac-
tion fraction of Tc-99m-DTPA by the dialyser was then
taken as the quotient, bloodKDTPA, divided by baseline Qb.
Urea clearance. Kt/V for urea (Kurea.t/Vurea) was cal-
culated from urea levels in blood samples obtained from
the patient before the start of dialysis and at its termi-
nation using a previously published formula (see Table
1) [10]. The value of Kurea.t/Vurea calculated from the
pre- to posturea concentration ratio was then corrected
for rebound using another previously published formula
[10]. The ratio of ultrafiltration to weight was taken
as the weight difference divided by predialysis weight.
Kurea.t/Vurea was divided by duration of dialysis (in min-
utes) and multiplied by an estimate of total body water
in milliliters (which is equivalent to Vurea) to give urea
clearance (bloodKurea). Vurea was calculated in two ways;
first, by multiplication of VDTPA by the factor 2.5 (assum-
ing that total body water is 2.5 times extracellular fluid
volume) and second, by scaling 40 L to the patient’s body
surface area based on height and predialysis weight [11].
bloodKurea was then divided by baseline Qb (mL/min) to
give an estimate of average urea extraction fraction across
the dialyzer for the whole period of dialysis.
Changes in Tc-99m-DTPA clearance in response to
changes in Qb and Qd. In addition to the average Tc-
99m-DTPA clearance, bloodKDTPA was measured at spec-
ified time points (“instantaneous” clearance) from a corr
recorded during changes in Qb and Qd. Instantaneous
extraction fraction by the artificial kidney at these points
was calculated as the quotient of corresponding values
of bloodKDTPA/Qb at the prevailing values of Qb. In-
stantaneous extraction fraction by the dialyzer was also
measured directly from Tc-99m-DTPA concentrations in
samples taken simultaneously from the lines entering and
returning from the dialyzer. These direct measurements
of extraction fraction (E) were compared with the indi-
rect values (EK) measured as bloodKDTPA/Qb.
Ultrafiltration
bloodKDTPA is the product of extraction fraction (E) and
blood flow (Qb) entering the dialyzer, plus a contribution
related to ultrafiltration (Qf):
bloodKDTPA = Qb.(1 − [Cout/Cin]) + Qf.(Cout/Cin)
(equation 1)
where E = 1 – (Cout/Cin) and C is blood Tc-99m-DTPA
concentration.
Qf, the net rate of fluid loss through the dialyzer, can be
assessed from the patient’s weight loss. The blood clear-
ance component resulting from ultrafiltration, given by
the final term in equation 1, was small compared with the
first term (see Results section) and therefore ignored. No
corrections were made for access recirculation.
Tc-99m-DTPA clearance in the setting of dialysis was
subjected to a computerized simulation based on a two-
compartmental model, as described in Appendix 1. Di-
alyzer function was modeled as shown in Appendix 2,
from which changes in Tc-99m-DTPA clearance were
predicted from changes in model variables.
Statistics
Results are expressed as the mean (SEM). Levels of
association between variables were assessed by Pearson’s
correlation coefficient. A P value of less than 0.05 was
considered to represent significance.
RESULTS
Tc-99m-DTPA clearance
In the five patients in whom the machine parameters
(i.e., Qb and Qd) were left unaltered over the entire
period of dialysis, the Tc-99m-DTPA clearance curve fol-
lowed a consistent pattern. When plotted on a logarithmic
scale, it was biexponential. After about 60 minutes, it be-
came monoexponential and remained as such for as long
as dialysis continued for both types of dialyzer (Fig. 1).
Two of these five patients were dialysed with A-18 and 3
with F-8. bloodKDTPA (and in parentheses plasmaKDTPA) val-
ues based on data acquired from 1 hour after the onset of
dialysis were similar between the two dialyzers: 165 (104)
and 176 (105) mL/min for A-18 and 154 (109), 173 (119),
and 175 (121) mL/min for F-8. Ignoring the influence
of changes in Qb and Qd, the overall mean bloodKDTPA
recorded from 1 hour in seven patients dialysed with A-
18 was 153 (6.4) mL/min and in eight patients dialyzed
with F-8, 168 (6.0) mL/min (P > 0.05). Corresponding val-
ues for plasmaKDTPA were 106 (2.9) and 113 (5.1) mL/min
(P > 0.05). Because the two dialyzers were not signifi-
cantly different with respect to Tc-99m-DTPA clearance,
data from them were pooled, giving mean plasmaKDTPA
and bloodKDTPA values based on the entire dialysis period
from 60 minutes of 110 (3.1) mL/min and 161 (4.7) mL/
min, respectively. Mean extraction fraction based on the
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Fig. 2. Relation between the rate constant of technetium-99m-
diethyltriaminepentaacetic acid (Tc-99m-DTPA) disappearance from
blood, a, and predialysis volume of distribution of (VDTPA). An expo-
nential fit has been used as a is asymptotic to the x axis. The inset shows
the similar relation between a and body surface area.
entire period of dialysis (from 60 minutes) was 0.54
(0.019).
The dependence of a on VDTPA (and on body surface
area) is illustrated by a close correlation between them
of r = 0.82 (Fig. 2). As predicted by the simulated model,
there was a rebound in Tc-99m-DTPA concentration af-
ter termination of dialysis. In the six patients in whom it
was measured, it amounted to 12.7% (2.9). As would be
expected, this rebound tended to correlate with a (r =
0.79; P ∼ 0.06). Moreover, it was similar in magnitude to
urea rebound, calculated from dialysis rate (Kurea/Vurea)
using the equation of Daugirdas [10], which was 13.2%
(0.7).
Urea clearance
The similarity between the performances of the two
dialyzers with respect to bloodKDTPA was also seen with
bloodKurea with respective values for A-18 and F-8 of 212
(11) and 235 (14) mL/min (P > 0.05) based on Vurea =
2.5 × VDTPA and 198 (11) and 224 (7.5) mL/min (P >
0.05) based on Vurea = 40 L/1.73 m2. Data from the two
dialyzers were therefore again pooled for the entire pa-
tient group. Mean “average” urea clearance was then 225
(9.5) mL/min based on an estimate of total body water
of 2.5 that of VDTPA, and 212 (13) mL/min based on to-
tal body water of 40 L/1.73 m2. The corresponding es-
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Fig. 3. Relation between technetium-99m-diethyltriaminepentaacetic
acid (Tc-99m-DTPA) and urea clearances. (A) Tc-99m-DTPA clear-
ance is expressed as plasma clearance (•) and as blood clearance [i.e.,
plasma clearance divided by (1 – hematocrit)] (). (B) The correspond-
ing decreases in urea and Tc-99m-DTPA concentrations between the
start and end of dialysis. The urea clearance (A) is based on a total body
water of 2.5 × VDTPA. Regression equations are shown. Correlation co-
efficients were lower when urea clearance was based on body surface
area with respective values of 0.64 (P < 0.02) and 0.13 (P > 0.05) for
bloodKDTPA and plasmaKDTPA, respectively. The concentration ratios in
b) have been expressed as the natural logarithms divided by dialysis
duration to make them comparable to urea and DTPA clearances, the
calculations of which are also based on log transformed concentration
ratios and dialysis duration. Regression lines are shown (A) and line of
identity (B).
timates of urea extraction fraction, using baseline Qb,
were 0.76 (0.03) and 0.72 (0.03). Average urea clearance
(with Vurea taken as 2.5 × VDTPA) correlated with both
average plasma and blood Tc-99m-DTPA clearances (r =
0.71) (N = 13) (P < 0.01) and (r = 0.60) (N = 13) (P <
0.05), respectively (Fig. 3A). A closer correlation was
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Fig. 4. Relation between the volumes of distribution of technetium-
99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) [measured be-
fore onset of dialysis (VDTPA)] and chromium-51 ethylenediaminete-
traacetic acid (Cr-51-EDTA) [measured after termination of dialysis
(VEDTA)]. The continuous line is identity.
observed, however, between the respective ratios of urea
and Tc-99m-DTPA concentrations in the blood samples
obtained before dialysis and at the termination of dialsy-
sis (r = 0.88) (N = 13) (P < 0.001) (Fig. 3B).
Volumes of distribution of radiotracers and
ultrafiltration rate
The volume of distribution of Tc-99m-DTPA (VDTPA)
prior to dialysis was 18.9 (1) L (or 17.1 [0.6] L/1.73 m2).
Mean weight reduction after dialysis was 1.68 (0.27) kg.
Postdialysis volume of distribution of Cr-51-EDTA was
measured in only six patients. In these six patients, VEDTA
was less than VDTPA by an average of 1.73 (0.74) L but
they showed good correlation with each other (Fig. 4)
consistent with previous claims [5, 6] that they are inter-
changeable for measurement of extracellular fluid vol-
ume. The reduction in body weight in these six patients
was 1.48 (0.57) kg which is well matched to the reduc-
tion of 1.73 L in extracellular fluid volume, confirming
that weight loss over the period of dialysis is almost ex-
clusively the result in loss of fluid from the extracellular
fluid compartment. Taking 1.5 L as representative of the
average fluid loss, Qf, amounted to less than 10 mL/min
(i.e., 1500 mL/240 min) and could therefore be considered
negligible compared with Qb
E
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Fig. 5. Relation between extraction fraction of technetium-99m-
diethyltriaminepentaacetic acid (Tc-99m-DTPA) measured (1) from
blood samples taken simultaneously from dialyzer inlet and outlet lines
(E) and (2) as the quotient, bloodKDTPA and Qb. As a result of changes
made in Qb and Qd during dialysis, there was a total of 27 corresponding
measurements. The continuous line is identity.
Effects of flow changes on Tc-99m-DTPA kinetics
Tc-99m-DTPA extraction fraction by the dialyzer (E)
was measured directly under varying conditions of Qb
and Qd in ten patients. Measured in six patients in whom
Qb was 250 to 350 mL/min and Qd was 500 mL/min, mean
E was 0.50 (0.013), similar to extraction fraction averaged
out for the entire dialysis period (see above).
Measured under varying conditions of Qd and Qb, E
showed a good correlation with extraction fraction (EK)
based on bloodKDTPA and Qb: Ek = 1.14.E + 0.057 (r =
0.74) (N = 27) (P < 0.001) (Fig. 5).
Table 2 compares changes in bloodKDTPA in response to
changes in (1) Qb at baseline Qd ( = 500 mL/min) and
(2) to changes in Qd at baseline Qb (250 to 350 mL/min)
with the corresponding changes predicted from the model
in Appendix 2. The relations between bloodKDTPA and
Qb and Qd are illustrated in Figure 6. In these experi-
ments, bloodKDTPA was calculated as described above as
the product of a corr and VDTPA and also as the product
of E (directly measured) and Qb. These two expressions
of bloodKDTPA agreed reasonably well with each other
(Fig. 7). Based on a corr and VDTPA, bloodKDTPA was 169
(9.1) at a Qb of 300 to 350 mL/min compared to 157
(8.8) mL/min at a Qb of 200 to 230 mL/min (P > 0.05)
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Table 2. Measured changes in
technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA)
blood clearance (bloodKDTPA) in responses to changes in dialyzer
blood flow (Qb) and dialysate flow (Qd) compared with changes
predicted from the model described in Appendix 2
% Change in Tc-99m-DTPA clearance (SEM)
Measured
Change in Qb or Qd Predicted Based on a corr.VDTPA Based on E
33% reduction in Qb −13.6 −5.9 (5.4) −21 (1.5)
Qd reduction from 500 −6.0 −14 (4.0)a −26 (5.9)b
to 300 mL/min
Qd increase from 500 +3.5 +4.9 (3.0) +0.9 (1.2)
to 800 mL/min
The volume of distribution of Tc-99m-DTPA is denoted VDTPA, the rate
constant of decrease in blood Tc-99m-DTPA concentration is denoted a and the
fraction of Tc-99m-DTPA extracted by the dialyzer, measured from samples
simultaneously collected in blood entering and leaving the dialyzer, is denoted E
aP < 0.01; bP < 0.05.
(Fig. 6A). There were only three recordings of changes in
bloodKDTPA based on E and Qb, but they gave a consistent
decrease from a mean of 157 (11) to 125 (11) mL/min at
Qb values of 300 to 350 mL/min and 200 to 230 mL/min,
respectively (Fig. 6B). With respect to variations in Qd,
bloodKDTPA based on a corr and VDTPA increased signifi-
cantly (P < 0.01) from 144 (7.6) at Qd = 300 mL/min to
169 (9.1) and 175 (11) mL/min at 500 and 800 mL/min
(Fig. 6C). bloodKDTPA based on E and Qb showed a simi-
lar trend with values of 117 (4.7), 157 (11), and 139 (7.9)
mL/min at 300, 500, and 800 mL/min (P < 0.05 for 300
vs. 800 mL/min; only three observations for 500 mL/min)
(Fig. 6D).
Considering all measurements of plasmaKDTPA based on
E and dialyser plasma flow, including isolated ones, there
was a clear association between plasmaKDTPA and plasma
flow (r = 0.89) (N = 13) (P < 0.001) (Fig. 8). There was,
however, only a weak (insignificant) corresponding cor-
relation when plasmaKDTPA was based on a corr and VDTPA.
DISCUSSION
The differences between Tc-99m-DTPA and urea with
respect to their distribution volumes and red cell penetra-
tion characteristics introduced some difficulties in com-
paring them in the dialysis settings described in this study.
The most difficult of these is the dependence of Tc-99m-
DTPA clearance on hematocrit. This radiotracer is ex-
cluded from red cells and so, in the setting of flow-limited
transport, its clearance across the dialyzer is dependent
on plasma flow rather than blood flow and therefore de-
pendent also on hematocrit. In contrast, for urea, which
freely enters red cells, plasma and blood clearances can
be regarded as identical. It therefore makes sense to use
blood clearance rather than plasma clearance when com-
paring Tc-99m-DTPA with urea. When hematocrit is high
then for a given blood flow, plasma flow will tend to be
low. For a given dialyzer mass transfer area coefficient,
Tc-99m-DTPA transport will therefore tend to be low.
Expressing Tc-99m-DTPA clearance as blood rather than
plasma clearance tends to compensate for this disadvan-
tage of Tc-99m-DTPA, but not entirely, so we are to some
extent still comparing apples with oranges when we com-
pare urea with Tc-99m-DTPA.
Kt/V is the variable conventionally used to quantify
the effectiveness of dialysis [1]. Urea is a small highly
diffusible molecule with a large volume of distribution
but Kt/V for urea is assumed to be representative of
the handling by the dialyzer of a range of molecules
of varying size. An attraction of Tc-99m-DTPA is that,
as a radiotracer, it can be used for continuous, real-
time, monitoring of dialysis performance. This gives a
robust measurement of clearance per unit distribution
volume, unlike Kt/V for urea which depends critically
on the technique of sampling at the end of dialysis and
requires a correction for rebound based on an historic
formula. The imprecision of these corrections can be ap-
preciated from the poorer correlations observed between
urea and Tc-99m-DTPA clearances compared with the
strong correlation between the “raw” post- to predialy-
sis ratios of urea and Tc-99m-DTPA (Fig. 3), neither of
which are subjected to any correction procedure but both
more or less equally affected by the venoarterial gradi-
ent (so-called cardiopulmonary recirculation, the tissue-
blood gradient from which rebound originates) and by
access recirculation. Although on-line measurement of
urea concentration has recently been described for con-
tinuous assessment [12], it is obtained from dialysate
concentration and is unlikely to have the temporal reso-
lution of Tc-99m-DTPA. Thus, it was possible to show in
this study that in the absence of interventions, and after
a period during which an interstitial fluid/plasma con-
centration gradient is established, Tc-99m-DTPA clear-
ance remained absolutely constant throughout dialysis
for periods of up to 5 hours. As for urea, the rebound in
plasma Tc-99m-DTPA concentration is the result of the
normalization of the concentration gradient established
between interstitial fluid (total body water for urea) and
plasma during dialysis. This gradient is fully established
from about 60 minutes after injection of any filtration
marker, and, in the presence of normal GFR, is about
15% for Tc-99m-DTPA [13], consistent with the rebound
observed here of 13%. The rebound tended to correlate
with a, which is to be expected as the concentration gra-
dient generated in the first place is dependent on a, just
as urea rebound is dependent on Kurea/Vurea. Rebound
for Tc-99m-DTPA was similar to that for urea. This was
in spite of their different distribution volumes and clear-
ances because their ratio of distribution volumes was sim-
ilar to their ratio of clearances. Rebound has also been
quantified for iohexol [12].
Tc-99m-DTPA also allows extracellular fluid volume
to be measured, at least prior to dialysis, and, combined
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Fig. 6. Relations between Qb (A and B)
and Qd (C and D) and technetium-99m-
diethyltriaminepentaacetic acid (Tc-99m-
DTPA) blood clearance (bloodKDTPA)
shown for individual patients. In (A and
C) bloodKDTPA was calculated by dividing
(a corr.VDTPA) by (1 – hematocrit) while in
(B and D) it was calculated as the product of
E and Qb. The bold squares are the mean
values at particular levels of Qb (180 to 200
mL/min and 270 to 350 mL/min) (A and
B) and Qd (300 mL/min, 500 mL/min, and
800 mL/min) (C and D) and the error bars
represent SEM.
with a postdialysis measurement of the same (or very sim-
ilar) volume using Cr-51-EDTA, enables measurement
of the change in extracellular fluid volume resulting from
dialysis. The recorded patient weight changes were very
similar to the changes in extracellular fluid volume con-
firming that weight lost over dialysis is almost exclusively
accounted for by loss of extracellular fluid, with no ap-
parent change in intracellular fluid volume.
Taking baseline Tc-99m-DTPA extraction fraction as
0.52, which, using the modeling approach described in
Appendix 2, gives an in vivo value for what is effectively
the dialyzer PS product of 178 mL/min. Based on a urea
extraction fraction of 0.74, the model gave a “PS prod-
uct” for urea of 579 mL/min. The ratio of these two PS
values (urea/Tc-99m-DTPA) was 3.3, similar to ratios of
PS products in continuous vascular endothelium in vivo
for urea and for solutes of a similar molecular size to
Tc-99m-DTPA [14], suggesting that the relative diffusion
rates of the 2 molecules through the dialyzer are simi-
lar to those through continuous vascular endothelium in
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Fig. 7. Relation between technetium-99m-diethyltriaminepentaacetic
acid (Tc-99m-DTPA) blood clearances (bloodKDTPA), respectively, cal-
culated (1) by dividing (acorr.VDTPA) by (1 – hematocrit) and (2) as the
product of E and Qb. The continuous line is identity.
vivo. Using the same baseline extraction fractions, the
model also enables the calculation of theoretically pre-
dicted changes in Tc-99m-DTPA clearance and extrac-
tion fraction in response to the changes in Qb and Qd
that were applied and to compare them with the changes
actually recorded. Agreements were reasonable, with the
predicted values falling within the limits of error of the
recorded values (Table 2).
Extraction fraction is critical in the dependence of so-
lute transfer on blood flow. Urea extraction fraction is
high, making its transfer blood flow–dependent, whereas
larger solutes that have lower extraction fractions will
display less blood flow-dependence. This explains, for ex-
ample, why the transferred mass of iohexol (molecular
weight 821 D), but not urea, was significantly greater af-
ter long dialysis (6 hours) at low Qb (118 mL/min) than
after short dialysis (3 hours) at high Qb (296 mL/min)
[12].
A potential source of error in the comparisons of clear-
ance parameters respectively based on directly measured
extraction fraction (E) and on a corr is the fact that the lat-
ter but not the former will be influenced by any residual
filtration function that the patient may have. Neverthe-
less, provided this remains unchanged, it will have little
impact on the interpretation of changes in a corr, or lack
of them as the case may be. In any event, residual na-
tive filtration function was negligible compared with the
equivalent GFR that is established during dialysis.
Reducing Qd from 500 to 300 mL/min had the effect
of significantly reducing Tc-99m-DTPA clearance but in-
creasing it from 500 to 800 mL/min had no clear effect.
An increase in Qd could increase clearance through two
mechanisms; first, by increasing the mean concentration
difference between plasma and dialysate and second, by
increasing the effective mass transfer coefficient or sur-
face area for exchange [15, 16]. Even if Qd was at a suf-
ficiently high level to render Tc-99m-DTPA transfer in-
dependent of it, an increase in effective surface area for
exchange should have increased clearance. The failure to
record an increase suggests that this effect of increasing
Qd is not important, at least for molecules like Tc-99m-
DTPA, or that alternatively flow becomes turbulent at
high rates [17]. The effect on clearance of a 33% reduc-
tion in Qb was somewhat ambiguous, although a reduc-
tion would have been expected on the basis of the model-
ing data. Moreover, plasmaKDTPA based on E and dialyzer
plasma flow, but not based on a corr and VDTPA, showed a
significant positive correlation with dialyser plasma flow.
CONCLUSION
The technique detailed in this study using the on-
line clearance of Tc-99m-DTPA is an accurate, reliable,
and reproducible technique, uninfluenced by cardiopul-
monary recirculation, access recirculation, or the re-
bound phenomenon, for the in vivo determination of
dialyzer function, knowledge of which may allow the
nephrologist to accurately assess and modify the dialy-
sis prescription with the assurance that the dialyzer fully
maintains function throughout the dialysis session. It pro-
vides a technique with the potential to monitor dialysis in
real-time for a range of molecules for which radioactive
labels are readily available and to assess the effects of al-
terations in dialysis parameters on dialyzer performance.
APPENDIX 1. COMPUTERIZED SIMULATION
A simulation of tracer clearance in the dialysis situation was per-
formed to give an idea of the expected pattern of change in plasma
concentration with time. A two-compartment model was used (Fig. 9).
Suitable parameters were chosen on the basis of previous multisample
plasma clearance measurements in subjects with varying levels of native
renal function. In the simulation, the tracer is introduced to compart-
ment 1 at time zero. After a period of 90 minutes, during which there is
no clearance from the system, the tracer is assumed to equilibrate be-
tween the two compartments. When dialysis is commenced, clearance
begins from compartment 1, is allowed to continue for 4 hours and then
stopped. In this two-compartment model, compartment 1 does not sim-
ply represent the plasma volume but is in fact considerably larger [17,
18]. Although a two-compartment model does not accurately simulate
the clearance curve within the first few minutes after introduction of
the tracer, for which a three-compartment model should be used, the
system nevertheless behaves as a two-compartment model after about
20 minutes.
A biexponential disappearance curve is predicted on the basis of the
model (Fig. 10). The first exponential corresponds to the generation
730 Bihl et al: In vivo hemodialysis performance
Dialyser plasma flow, mL/min
100 150 200 250 100 150 200 250
pl
as
m
a K
D
TP
A,
 
m
L/
m
in
60
70
80
90
130
120
110
100
140
150
160
r = 0.89; N = 13; P < 0.001
r = 0.31; N = 23; P > 0.1
E × Qb.[1 − hematocrit] αcorr.VDTPA
Fig. 8. Relation between plasma
technetium-99m-diethyltriaminepentaacetic
acid (Tc-99m-DTPA) clearance
(plasmaKDTPA) and dialyzer plasma flow
[calculated as the product of Qb and (1 –
hematocrit)]. Left panel, plasmaKDTPA has
been calculated as the product of E and Qb (1
– hematocrit). Right panel, plasmaKDTPA is the
product of a corr and VDTPA. The continuous
line in the left panel is the regression line.
Compartment 2
Compartment 1
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Fig. 9. Compartmental model depicting the distributions of
technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) and
chromium-51-ethylenediaminetetraacetic acie (Cr-51-EDTA).
of a concentration gradient between the two functional volumes at the
onset of dialysis, a gradient which is predicted to take about 60 minutes
to become constant relative to plasma concentration. The model also
predicts a rebound of the plasma Tc-99m-DTPA concentration when
dialysis is terminated that is due to reequilibration of concentrations
between the two functional volumes.
APPENDIX 2. DIALYSIS MODEL
A computerized simulation was written to model the concentrations
within a dialyzer arranged such that dialysate and blood are flowing
in opposite directions and that the dialysate entering the dialyzer is
across the membrane from blood just before it leaves the dialyzer. The
concentration of the solute to be modeled is assumed to be zero in the
dialysate entering the dialyzer. The dialyser is then considered to be
divided into a finite number of cells (100) on each side of the dialysis
membrane and the concentration within any one cell is assumed to be
constant (Fig. 11). The simulation models unit time intervals during
which the solute flows between adjacent cells on the same side of the
membrane while at the same time crossing the membrane as a result
Compartment 2
Compartment 1
lo
g(c
on
ce
ntr
ati
on
)
0 60 120 180 240 300 360
Minutes
Fig. 10. Compartmental time-concentration curves predicted by
the model in Fig. 9 following injection of technetium-99m-
diethyltriaminepentaacetic acid (Tc-99m-DTPA) into compartment 1.
In the absence of any filtration function, the concentrations in the two
compartments are predicted to equalize before dialysis is started. Af-
ter dialysis is started, the concentration in compartment 2 (fine line) is
predicted to exceed that in compartment 1 (bold line) while both fall
exponentially with the same rate constant. After dialysis is stopped, the
concentrations equalize again, a process that leads to a “rebound” (i.e.,
increase) in the concentration in compartment 1.
Blood
Dialysate
Fig. 11. Model of dialysis to predict changes in solute clearance as a
result of changes in flow rates of blood and dialysate.
of diffusion. The simulation is run until a steady state is reached, at
which point there is a concentration gradient in blood and dialysate
along the length of the membrane. The simulation was then used to find
a mass transfer coefficient that gives a particular extraction fraction at
standard blood and dialysate flow rates [0.52 for Tc-99m-DTPA and
0.74 for urea (see Results section)] and then to model how changes in
dialysate or blood flow rates would affect the extraction fraction. The
effect of ultrafiltration was ignored. For Tc-99m-DTPA, the hematocit
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was assumed to be 0.3 so that plasma flow rather than blood flow was
used. It was assumed that urea moves freely between plasma and red
cells within which concentrations would then be identical.
Reprint requests to Professor A. Michael Peters, Department of Nu-
clear Medicine, Royal Sussex County Hospital, Eastern Road, Brighton
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